Copy For Citation
Uysal M., Bozcuk H., Göksu S. S., Tatlı A. M., Arslan D., Gunduz S., ...More
BIOMEDICINE & PHARMACOTHERAPY, vol.68, no.4, pp.409-412, 2014 (SCI-Expanded)
-
Publication Type:
Article / Article
-
Volume:
68
Issue:
4
-
Publication Date:
2014
-
Doi Number:
10.1016/j.biopha.2014.03.002
-
Journal Name:
BIOMEDICINE & PHARMACOTHERAPY
-
Journal Indexes:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Page Numbers:
pp.409-412
-
Keywords:
Bevacizumab, Metastatic colorectal cancer, Prognostic and predictive factors, Proteinuria, PREOPERATIVE CARCINOEMBRYONIC ANTIGEN, FLUOROURACIL, LEUCOVORIN, HYPERTENSION, IRINOTECAN, OUTCOMES
-
Akdeniz University Affiliated:
Yes
Abstract
Background: The beneficial effects of bevacizumab, a widely used agent in metastatic colorectal cancer (mCRC), on clinical survival have been proven. This study investigated the correlation of the clinical benefits and prognosis with proteinuria and other parameters.